Tigecycline salvage therapy for critically ill children with multidrug-resistant/extensively drug-resistant infections after surgery

Tigecycline salvage therapy was successful in 86% of critically ill pediatric patients with MDR/XDR infections after surgery, with no severe adverse effects.